Aug 10, 2018
Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - Evaluation of Approx. 135 Novel Drug Candidates Across Various Stages of Development
Jun 25, 2018
Global Cystic Fibrosis Industry
Jun 25, 2018
BNBuilders Completes Construction on Vertex Pharmaceuticals Research Center in San Diego
Jun 06, 2018
Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy
Jun 01, 2018
Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference
May 08, 2018
Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis
Apr 17, 2018
Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy
Apr 10, 2018
Quotidian Technical Highlights on Selected Biotech Stocks -- Vertex Pharma, VIVUS, Voyager Therapeutics, and Zosano Pharma
Apr 04, 2018
Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
Mar 13, 2018
Global Respiratory Disorders Novel Drugs and Smart Devices Research Report 2018 Featuring 160 Leading Companies & Organisations
Feb 09, 2018
Global Cystic Fibrosis Therapeutics Market 2018-2022 by Drug Class - Market Expected to Grow at a CAGR of 17.28%
Nov 10, 2017
Stocks Under Scanner in the Biotech Space -- Sangamo Therapeutics, Vertex Pharma, Athersys, and AVEO Pharma
Oct 12, 2017
Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis - Global Forecast to 2024
Oct 11, 2017
Cystic Fibrosis - Pipeline Review, H2 2017
Sep 28, 2017
Stock Performance Review on Biotech Industry -- Vertex Pharma, Axovant Sciences, Cerecor, and Ocular Therapeutix
Aug 07, 2017
Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma
Jul 24, 2017
Global Genes Announces RARE Champion of Hope Award Recipients to be Honored at 6th Annual RARE Tribute and Patient Advocacy Summit
Jul 24, 2017
Global Cystic Fibrosis Therapeutics Market 2016-2022: Profiles of Key players - Genentech, Novartis, Vertex, Abbott, Gilead Sciences & Allergan
Jun 27, 2017
Cystic Fibrosis Therapeutics Market Size Worth $13.9 Billion By 2025: Grand View Research, Inc.
Jun 22, 2017
BNBuilders Tops Out Vertex Pharmaceuticals New Building